A deletion polymorphism due to Alu-Alu recombination in intron 2 of the retinoblastoma gene: Association with human gliomas

Molecular Carcinogenesis

Volumn 19, Issue 2, 1997, Pages 69-73

  Rothberg, Paul G ^a,b   Ponnuru, Satish ^a,c   Baker, Darren ^a   Bradley, John F ^a   Freeman, Arnold I ^a,b,d   Cibis, Gerhard W ^a,b   Harris, David J ^a,b   Heruth, Daniel P ^a,b,e  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e WILLIAM JEWELL COLLEGE   (United States)

Author keywords

Brain cancer; RB gene; SINE; Tumor suppessor

Indexed keywords

RETINOBLASTOMA PROTEIN;

ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BLOTTING, SOUTHERN; BRAIN NEOPLASMS; GENES, RETINOBLASTOMA; GLIOMA; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RECOMBINATION, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID; SEQUENCE DELETION;

MARTES PENNANTI;

EID: 0030747623     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199707)19:2<69::AID-MC1>3.0.CO;2-G     Document Type: Article

References (28)

1. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-646, 1986.
2. Lee W-H, Bookstein R, Hong F, Young L-J, Shew J-Y, Lee EY-H. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science 235:1394-1399, 1987.
3. Benedict WF, Xu H-J, Hu S-X, Takahashi R. Role of the retinoblastoma gene in the initiation and progression of human cancer. J Clin Invest 85:988-993, 1990.
4. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53:661-671, 1986.
5. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology 95:1583-1587, 1988.
6. Bello MJ, de Campos JM, Kusak ME, et al. Molecular analysis of genomic abnormalities in human gliomas. Cancer Genet Cytogenet 73:122-129, 1994.
7. Henson JW, Schnitker BL, Correa KM, et al. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36:714-721, 1994.
8. James CD, Carlbom E, Dumanski JP, et al. Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546-5551, 1988.
9. Venter DJ, Bevan KL, Ludwig RL, et al. Retinoblastoma gene deletions in human glioblastomas. Oncogene 6:445-448, 1991.
10. Godbout R, Miyakoshi J, Dobler KD, et al. Lack of expression of tumor-suppressor genes in human malignant glioma cell lines. Oncogene 7:1879-1884, 1992.
11. Hamel W, Westphal M, Shepard HM. Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease. J Neurooncol 16:159-165, 1993.
12. Lücke M, Hamel W, Lüdecke DK, Herrmann H-D, Westphal M. Expression of retinoblastoma gene in human intracranial neoplasms. Int J Oncol 4:885-890, 1994.
13. INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res 55:4833-4836, 1995.
14. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 56:150-153, 1996.
15. Herald KM, Rothberg PG. Amplification and activation of the c-myc oncogene in adenocarcinoma of the large bowel. In: Herrera L (ed). Familial Adenomatous Polyposis, Alan R. Liss, Inc., New York, 1990, pp. 361-369.
16. Herold KM, Rothberg PG. Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells. Oncogene 3:423-428, 1988.
17. Toguchida J, McGee TL, Paterson JC, et al. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 17:535-543, 1993.
18. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP. Allele-specific hypermethylation of the Retinoblastoma tumor-suppressor gene. Am J Hum Genet 48:880-888, 1991.
19. Lehrman MA, Goldstein JL, Russell DW, Brown MS. Duplication of seven exons in LDL receptor gene caused by Alu-Alu recombination in a subject with familial hypercholesterolemia. Cell 48:827-835, 1987.
20. Lehrman MA, Russell DW, Goldstein JL, Brown MS. Alu-Alu recombination deletes splice acceptor sites and produces secreted low density lipoprotein receptor in a subject with familial hypercholesterolemia. J Biol Chem 262:3354-3361, 1987.
21. Hobbs HH, Brown MS, Goldstein JL, Russell DW. Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hypercholesterolemia. J Biol Chem 261:13114-13120, 1986.
22. Efstradiadis A, Posakony JW, Maniatis T, et al. The structure and evolution of the human β-globin gene family. Cell 21:653-668, 1980.
23. Kato MV, Ishizaki K, Toguchida J, et al. Mutations in the retinoblastoma gene and their expression in somatic and tumor cells of patients with hereditary retinoblastoma. Hum Mutat 3:44-51, 1994.
24. Canning S, Dryja TP. Short, direct repeats at the breakpoints of deletions of the retinoblastoma gene. Proc Natl Acad Sci USA 86:5044-5048, 1989.
25. Hashimoto T, Takahashi R, Yandell DW, et al. Characterization of intragenic deletions in two sporadic germinal mutation cases of retinoblastoma resulting in abnormal gene expression. Oncogene 6:463-469, 1991.
26. Greger V, Passarge E, Horsthemke B. Somatic mosaicism in a patient with bilateral retinoblastoma. Am J Hum Genet 46:1187-1193, 1990.
27. Lee EY, Bookstein R, Young LJ, Lin CJ, Rosenfeld MG, Lee WH. Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79. Proc Natl Acad Sci USA 85:6017-6021, 1988.
28. Bookstein R, Lee EY, Peccei A, Lee WH. Human retinoblastoma gene: Long-range mapping and analysis of its deletion in a breast cancer cell line. Mol Cell Biol 9:1628-1634, 1989.